Personalized Detection of Circulating Tumor DNA Antedates Breast Cancer Metastatic Recurrence

This study demonstrates that patient-specific ctDNA analysis can be a sensitive and specific approach for disease surveillance for patients with breast cancer. More importantly, earlier detection of up to 2 years provides a possible window for therapeutic intervention.